New York Life Investment Management’s Lam Research LRCX Stock Holding History

New York Life Investment Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.1M	Buy	205,583 +5,337	+3%	+$1.62M	0.62%	33
2026 Q1	$42.8M	Buy	200,246 +13,345	+7%	+$2.98M	0.36%	53
2025 Q4	$32M	Buy	186,901 +1,121	+0.6%	+$174K	0.28%	67
2025 Q3	$24.9M	Sell	185,780 -6,478	-3%	-$686K	0.22%	86
2025 Q2	$18.7M	Buy	192,258 +1,472	+0.8%	+$117K	0.18%	116
2025 Q1	$13.9M	Sell	190,786 -1,614	-0.8%	-$127K	0.14%	136
2024 Q4	$13.9M	Sell	192,400 -1,710	-0.9%	-$130K	0.14%	137
2024 Q3	$15.8M	Sell	194,110 -5,370	-3%	-$467K	0.15%	135
2024 Q2	$21.2M	Buy	199,480 +1,000	+0.5%	+$95.9K	0.21%	91
2024 Q1	$19.3M	Sell	198,480 -8,580	-4%	-$755K	0.19%	98
2023 Q4	$16.2M	Sell	207,060 -890	-0.4%	-$60.7K	0.17%	116
2023 Q3	$13M	Sell	207,950 -3,060	-1%	-$201K	0.14%	137
2023 Q2	$13.6M	Sell	211,010 -2,320	-1%	-$131K	0.14%	142
2023 Q1	$11.3M	Sell	213,330 -1,990	-0.9%	-$97.7K	0.13%	164
2022 Q4	$9.05M	Sell	215,320 -1,270	-0.6%	-$53.1K	0.1%	206
2022 Q3	$7.93M	Sell	216,590 -2,140	-1%	-$95.3K	0.1%	223
2022 Q2	$9.32M	Buy	+218,730	New	+$10.4M	0.11%	199

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New York Life Investment Management's LRCX Position: Q2 2026 in Review

New York Life Investment Management increased its Lam Research (LRCX) stake by 2.7% in Q2 2026, buying an estimated $1.62M and bringing the position to 205,583 shares worth $89.1M. The position accounts for 0.62% of the portfolio, ranked #33.

New York Life Investment Management first reported a position in LRCX in Q2 2022 and has held it in 17 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

New York Life Investment Management held 205,583 shares of Lam Research worth $89.1M as of Q2 2026.
New York Life Investment Management bought 5,337 Lam Research shares in Q2 2026, an estimated $1.62M.
Lam Research made up 0.62% of New York Life Investment Management's portfolio in Q2 2026, its #33 holding.
New York Life Investment Management first reported a position in Lam Research in Q2 2022 and has held it in 17 quarters since.
3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.